Qualcomm Expands Collaboration with Novartis for Connected COPD Therapy
Qualcomm Incorporated (NASDAQ: QCOM) today announced that its subsidiary, Qualcomm Life, Inc., and Novartis are expanding their global connected therapy management collaboration. Novartis will leverage Qualcomm Life's connectivity solutions to power its next-generation connected Breezhaler™, the inhaler for its Chronic Obstructive Pulmonary Disease (COPD) portfolio.
Qualcomm Life is developing the reference design for the small, low-power, disposable module to connect the next generation Breezhaler, which is part of Novartis' leading portfolio of COPD treatments comprised of Onbrez™, Seebri™ and Ultibro™, with Ultibro leading the category in the LABA/ LAMA therapy class. The module is designed to seamlessly connect with Qualcomm Life's 2net™ Platform, and can detect and report inhaler usage, as well as the duration of the patient's inhalation which indicates quality of the inhalation.
"This is an exciting time for health care as we see the proliferation of the Internet of Medical Things," said Rick Valencia, senior vice president and general manager, Qualcomm Life, Inc. "Through our expanded collaboration with Novartis, we are able to deliver a frictionless digital health experience to their COPD patients."
Through this collaboration, Novartis aims to be the first company with a completely integrated, connected delivery device that will provide a simple experience for patients, eliminate the need to assemble the device themselves, and enable them to more easily manage their chronic disease. With near-real time data capture from the patient and the connected device, Novartis aims to improve medication adherence and ultimately health outcomes for COPD patients.
Novartis plans to launch the new connected Breezhaler in 2019 following manufacturing, testing and regulatory approvals.
About Qualcomm Incorporated
Qualcomm Incorporated (NASDAQ: QCOM) is a world leader in 3G, 4G and next-generation wireless technologies. Qualcomm Incorporated includes Qualcomm's licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm's engineering, research and development functions, and substantially all of its products and services businesses, including its semiconductor business, QCT. For more than 30 years, Qualcomm ideas and inventions have driven the evolution of digital communications, linking people everywhere more closely to information, entertainment and each other.
2net is a trademark of Qualcomm Incorporated, registered in the United States and other countries.
Most Popular Now
You might not want to depend on your smartphone app alone to help you avoid or achieve pregnancy, say the authors of a new study. A review of nearly 100 fertility awarene...Read more
What have the best brains of Europe come up with to improve health and wellbeing with the help of Information and Communication Technology (ICT)? This report offers an ...Read more
Machine learning is a type of artificial intelligence that allows computer programs to learn when exposed to new data without being programmed. Now, researchers in The Ne...Read more
Wearable devices can give away your passwords, according to new research. In the paper "Friend or Foe?: Your Wearable Devices Reveal Your Personal PIN" scientists from Bi...Read more
A clinical trial testing mobile videoconferencing as a means for physicians to diagnose stroke patients while they're being transported to the hospital has found that a t...Read more
That's the question Drexel University researchers hope to answer with one of two new studies launching this month. They have developed a computer game and smartphone app ...Read more
Royal Philips (NYSE: PHG, AEX: PHIA) has signed a licensing agreement with Visiopharm to offer their breast cancer panel software algorithms  with Philips IntelliSite ...Read more
Imagine a companion who is able to constantly motivate you, actively encourages you and changes your bad habits into healthy ones. A companion who is always present and w...Read more
Scientists at the Montreal Neurological Institute and Hospital have used a powerful tool to better understand the progression of late-onset Alzheimer's disease (LOAD), id...Read more